AOBBIY Tattoo Numbing Cream

Manufacturer
Shenzhen Situya Trading Co., Ltd.
Effective date
2023-07-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:29:11

Label at a glance#

ProductAOBBIY Tattoo Numbing Cream
Active ingredientLIDOCAINE
Label structure14 sections

Dosage and administration

Apply up to 3 times a day. Children (under 12 years of age): consult a doctor. Adults: before applying this product, clean the affected area with mild soap and warm water and rinse thoroughly. Pat dry the area with a soft cloth or tissue.

Storage and handling

Keep away from direct sunlight or heat. Store at room temperature 59°-86°F (15°-30°C).

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

LIDOCAINE 5%

Purpose

OTC - PURPOSE SECTION

Local Anesthetic

Use

INDICATIONS & USAGE SECTION

temporarily relieves local and anorectal discomfort associated with the anorectal disorder or swelling.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

pregnant or breastfeeding, ask your doctor before use.
in case of accidental overdose, seek immediate medical help or contact the Poison Control Center.
seal is broken or missing.

When Using

OTC - WHEN USING SECTION

do not exceed the recommended daily dosage unless directed by a doctor. Certain sensitive individuals may have an allergic reaction to some of the ingredients of this product.
do not put this cream into the rectum using your fingers, applicators, or any medical devices.

Stop Use

OTC - STOP USE SECTION

the symptom being treated does not improve, or if redness, irritation, swelling, pain, or other symptoms appear or worsen. Seek medical help right away.

Keep Oot Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, seek medical help right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Apply up to 3 times a day.
Children (under 12 years of age): consult a doctor.
Adults: before applying this product, clean the affected area with mild soap and warm water and rinse thoroughly. Pat dry the area with a soft cloth or tissue.

Other information

STORAGE AND HANDLING SECTION

Keep away from direct sunlight or heat.
Store at room temperature 59°-86°F (15°-30°C).

Inactive ingredients

INACTIVE INGREDIENT SECTION

Aqua, Propylene Glycol, Carbomer 934, Lecithin (Soybean), Tocopheryl Acetate, Benzyl Alcohol.

Notice

WARNINGS AND PRECAUTIONS SECTION

Due to the difference in temperature and skin type, the numbness effect duration will differ. Testing in a small area first is recommended to ensure the best numbness effect.

Correct Use Steps Before Tattooing

DESCRIPTION SECTION

1. Clean your hands and the treatment area with soft soap and warm water, rinse thoroughly, then gently pat dry.
2. Apply a thick layer of the numbing cream onto
the treatment area.
3. Wrap tightly with plastic wrap and wait 45-60 minutes for the numbness to peak. (The peak lasts up to 6 hours.) 4. Wipe away the residue with a soft cloth or tissue.
5. Begin the procedure.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

22

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82739-01482739-014-01, 82739-014-02, 82739-014-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
29eae75d-93db-7a5a-e063-6394a90ac0c0ffb5226b-b42d-bf4f-e053-6294a90a4b682024-12-23WarningsExact identifier
spl set id: ffb5226b-b42d-bf4f-e053-6294a90a4b68

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.